Related Experiment Videos
[Coronary revascularization in the diabetic]
1Service de Cardiologie, Hôpital Bichat, Paris, France.
Insights
Diabetic patients face higher risks after balloon angioplasty. Surgery may be better than percutaneous transluminal coronary angioplasty (PTCA) for multivessel disease in diabetics, but PTCA is still needed for some cases.
Area of Science:
- Cardiology
- Diabetology
- Interventional Cardiology
Context:
- Diabetes mellitus significantly increases complication risks post-angioplasty.
- Multivessel coronary artery disease in diabetics poses higher mortality risks with percutaneous transluminal coronary angioplasty (PTCA) compared to surgery.
- PTCA remains a necessary revascularization option for diabetic patients with single-vessel disease or those unsuitable for surgery.
Purpose:
- To evaluate the risks and benefits of percutaneous transluminal coronary angioplasty (PTCA) in diabetic patients.
- To analyze the impact of diabetes on short- and long-term outcomes following coronary angioplasty.
- To highlight the need for further research into advanced percutaneous interventions for diabetic patients.
Summary:
- Diabetes mellitus is linked to increased short- and long-term complications after balloon angioplasty.
- For diabetic patients with multivessel disease suitable for both surgery and PTCA, surgical revascularization may offer better long-term survival, warranting caution in routine PTCA selection.
- Despite risks, PTCA is essential for diabetic patients with single-vessel disease or poor surgical candidacy.
Impact:
- Findings suggest a need for careful patient selection when considering PTCA versus surgery for diabetic patients with multivessel disease.
- Emphasizes the continued importance of PTCA for specific diabetic populations.
- Underscores the need for further investigation into the efficacy of newer technologies like stents and glycoprotein IIb/IIIa inhibitors in diabetic patients undergoing percutaneous coronary interventions.
Abstract:
Diabetes mellitus is associated with increased risk of short and long-term complications after balloon angioplasty. In patients with multivessel disease, there may be a substantial increase in long-term mortality when percutaneous transluminal coronary angioplasty (PTCA) is preferred over surgery in patients who are amenable to both techniques, which should lead to caution in selecting PTCA as a routine revascularization method for these patients. However, many diabetic patients will still require revascularization with PTCA, either for single-vessel disease or because they are poor surgical candidates. Finally, the impact of recent advances, such as stents and glycoprotein IIb/IIIa inhibitors, on the short and long-term results of percutaneous interventions is still not fully defined and deserves further study.